Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [Phase 1]

View source ↗

Summary

A Phase 1 trial of a combination chemotherapy regimen for patients with recurrent, refractory, or metastatic solid tumors and lymphomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Pancreatic Cancer

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Colorectal Cancer, Esophageal Cancer | Phase 1 | Status: COMPLETED